Current and historical daily PE Ratio for Cytek Biosciences Inc (
) from 2021 to Jul 18 2025. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Cytek Biosciences stock (CTKB) PE ratio as of Jul 18 2025 is 0.
More Details
Cytek Biosciences Inc (CTKB) PE Ratio (TTM) Chart
Cytek Biosciences Inc (CTKB) PE Ratio (TTM) Historical Data
View and export this data going back to 2021. Start your Free Trial
Total 1001
- 1
- 2
- 3
- 4
- 5
- 6
- 12
| Cytek Biosciences PE Ratio (TTM) Historical Data | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data | ||||||
| 2025-07-18 | At Loss | 0 | 0 | 0 | 2025-05-13 | At Loss | 0 | 0 | 0 |
| 2025-07-17 | At Loss | 0 | 0 | 0 | 2025-05-12 | At Loss | 0 | 0 | 0 |
| 2025-07-16 | At Loss | 0 | 0 | 0 | 2025-05-09 | At Loss | 0 | 0 | 0 |
| 2025-07-15 | At Loss | 0 | 0 | 0 | 2025-05-08 | At Loss | 0 | 0 | 0 |
| 2025-07-14 | At Loss | 0 | 0 | 0 | 2025-05-07 | At Loss | 0 | 0 | 0 |
| 2025-07-11 | At Loss | 0 | 0 | 0 | 2025-05-06 | At Loss | 0 | 0 | 0 |
| 2025-07-10 | At Loss | 0 | 0 | 0 | 2025-05-05 | At Loss | 0 | 0 | 0 |
| 2025-07-09 | At Loss | 0 | 0 | 0 | 2025-05-02 | At Loss | 0 | 0 | 0 |
| 2025-07-08 | At Loss | 0 | 0 | 0 | 2025-05-01 | At Loss | 0 | 0 | 0 |
| 2025-07-07 | At Loss | 0 | 0 | 0 | 2025-04-30 | At Loss | 0 | 0 | 0 |
| 2025-07-03 | At Loss | 0 | 0 | 0 | 2025-04-29 | At Loss | 0 | 0 | 0 |
| 2025-07-02 | At Loss | 0 | 0 | 0 | 2025-04-28 | At Loss | 0 | 0 | 0 |
| 2025-07-01 | At Loss | 0 | 0 | 0 | 2025-04-25 | At Loss | 0 | 0 | 0 |
| 2025-06-30 | At Loss | 0 | 0 | 0 | 2025-04-24 | At Loss | 0 | 0 | 0 |
| 2025-06-27 | At Loss | 0 | 0 | 0 | 2025-04-23 | At Loss | 0 | 0 | 0 |
| 2025-06-26 | At Loss | 0 | 0 | 0 | 2025-04-22 | At Loss | 0 | 0 | 0 |
| 2025-06-25 | At Loss | 0 | 0 | 0 | 2025-04-21 | At Loss | 0 | 0 | 0 |
| 2025-06-24 | At Loss | 0 | 0 | 0 | 2025-04-17 | At Loss | 0 | 0 | 0 |
| 2025-06-23 | At Loss | 0 | 0 | 0 | 2025-04-16 | At Loss | 0 | 0 | 0 |
| 2025-06-20 | At Loss | 0 | 0 | 0 | 2025-04-15 | At Loss | 0 | 0 | 0 |
| 2025-06-18 | At Loss | 0 | 0 | 0 | 2025-04-14 | At Loss | 0 | 0 | 0 |
| 2025-06-17 | At Loss | 0 | 0 | 0 | 2025-04-11 | At Loss | 0 | 0 | 0 |
| 2025-06-16 | At Loss | 0 | 0 | 0 | 2025-04-10 | At Loss | 0 | 0 | 0 |
| 2025-06-13 | At Loss | 0 | 0 | 0 | 2025-04-09 | At Loss | 0 | 0 | 0 |
| 2025-06-12 | At Loss | 0 | 0 | 0 | 2025-04-08 | At Loss | 0 | 0 | 0 |
| 2025-06-11 | At Loss | 0 | 0 | 0 | 2025-04-07 | At Loss | 0 | 0 | 0 |
| 2025-06-10 | At Loss | 0 | 0 | 0 | 2025-04-04 | At Loss | 0 | 0 | 0 |
| 2025-06-09 | At Loss | 0 | 0 | 0 | 2025-04-03 | At Loss | 0 | 0 | 0 |
| 2025-06-06 | At Loss | 0 | 0 | 0 | 2025-04-02 | At Loss | 0 | 0 | 0 |
| 2025-06-05 | At Loss | 0 | 0 | 0 | 2025-04-01 | At Loss | 0 | 0 | 0 |
| 2025-06-04 | At Loss | 0 | 0 | 0 | 2025-03-31 | At Loss | 0 | 0 | 0 |
| 2025-06-03 | At Loss | 0 | 0 | 0 | 2025-03-28 | At Loss | 0 | 0 | 0 |
| 2025-06-02 | At Loss | 0 | 0 | 0 | 2025-03-27 | At Loss | 0 | 0 | 0 |
| 2025-05-30 | At Loss | 0 | 0 | 0 | 2025-03-26 | At Loss | 0 | 0 | 0 |
| 2025-05-29 | At Loss | 0 | 0 | 0 | 2025-03-25 | At Loss | 0 | 0 | 0 |
| 2025-05-28 | At Loss | 0 | 0 | 0 | 2025-03-24 | At Loss | 0 | 0 | 0 |
| 2025-05-27 | At Loss | 0 | 0 | 0 | 2025-03-21 | At Loss | 0 | 0 | 0 |
| 2025-05-23 | At Loss | 0 | 0 | 0 | 2025-03-20 | At Loss | 0 | 0 | 0 |
| 2025-05-22 | At Loss | 0 | 0 | 0 | 2025-03-19 | At Loss | 0 | 0 | 0 |
| 2025-05-21 | At Loss | 0 | 0 | 0 | 2025-03-18 | At Loss | 0 | 0 | 0 |
| 2025-05-20 | At Loss | 0 | 0 | 0 | 2025-03-17 | At Loss | 0 | 0 | 0 |
| 2025-05-19 | At Loss | 0 | 0 | 0 | 2025-03-14 | At Loss | 0 | 0 | 0 |
| 2025-05-16 | At Loss | 0 | 0 | 0 | 2025-03-13 | At Loss | 0 | 0 | 0 |
| 2025-05-15 | At Loss | 0 | 0 | 0 | 2025-03-12 | At Loss | 0 | 0 | 0 |
| 2025-05-14 | At Loss | 0 | 0 | 0 | 2025-03-11 | At Loss | 0 | 0 | 0 |
Cytek Biosciences Inc (CTKB) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Cytek Biosciences Inc
NAICS : 423450
SIC : 3845
ISIN : US23285D1090
Description
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers